Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation-Reference-Cited by-同舟云学术

Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation

Published:2017-11 Issue:11 Volume:23 Page:1887-1894
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Imus Philip H.,Blackford Amanda L.,Bettinotti Maria,Iglehart Brian,Dietrich August,Tucker Noah,Symons Heather,Cooke Kenneth R.,Luznik Leo,Fuchs Ephraim J.,Brodsky Robert A.,Matsui William H.,Huff Carol Ann,Gladstone Douglas,Ambinder Richard F.,Borrello Ivan M.,Swinnen Lode J.,Jones Richard J.,Bolaños-Meade Javier

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

1. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions;Huff;Biol Blood Marrow Transplant,2006

2. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation;Collins;J Clin Oncol,1997

3. Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation;Shimoni;Biol Blood Marrow Transplant,2001

4. CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study;Alyea;Bone Marrow Transplant,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tricking the trickster: precision medicine approaches to counteract leukemia immune escape after transplant;Blood;2024-06-27

2. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy;Transplantation and Cellular Therapy;2024-05

3. The history of haploidentical stem cell transplantation: a trip from the bench to the bedside;Hematology;2024-04-30

4. How I reduce and treat posttransplant relapse of MDS;Blood;2024-04-04

5. Risk factors and survival analysis of human leukocyte antigen loss in relapsed acute myeloid leukaemia/myelodysplastic syndrome patients after allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2024-02-07